Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Pacific Biosciences of California Inc’s current trading price is -58.09% away from its 52-week high, while its distance from the 52-week low is 33.94%. The stock’s price range over this period has fluctuated between $0.85 and $2.72. The company, operating within the financial sector, had a trading volume of approximately 12.91 million for the day, which was noticeably higher than the average daily share volume of 8.65 million over the last 3 months.
Pacific Biosciences of California Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $2.72 on 11/07/24 and a low of $0.85 for the same time frame on 05/28/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Pacific Biosciences of California Inc (PACB) has experienced a quarterly decline of -14.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 342.10M and boasts a workforce of 575 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 7.63. Similarly, the long-term debt-to-equity ratio is also 7.60.
PACB Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -37.70% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -37.70%. Over the past 30 days, the price of PACB has fallen by 0.88%. And in the last five days, it has surged by 18.29%.
